Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway
Article in Biomedicine & Pharmacotherapy (May 2024)
The most recent citing publications are shown below. View all 90 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (May 2024)
Preprint in Research Square (May 2024)
Article in Journal of Ethnopharmacology (May 2024)